Glenn M. Chertow
Publication Details
-
Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.
Am Heart J. 2011; (2): 324-30
Persons with end-stage renal disease (ESRD) on hemodialysis carry an exceptionally high burden of cardiovascular disease. Angiotensin-converting enzyme inhibitors (ACEIs) are recommended for patients on dialysis, but there are few data regarding their effectiveness in ESRD.
Help